A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents
about
Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action.GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice.Docosahexaenoic acid (DHA) at the sn-2 position of triacylglycerols increases DHA incorporation in brown, but not in white adipose tissue, of hamsters.Antidyslipidemic potential of a novel farnesoid X receptor antagonist in a hamster model of dyslipidemia: Comparative studies of other nonstatin agents.Plasma lipidomic analysis reveals strong similarities between lipid fingerprints in human, hamster and mouse compared to other animal species
P2860
A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A Hamster Model of Diet-Induce ...... ic and Lipid Modulating Agents
@ast
A Hamster Model of Diet-Induce ...... ic and Lipid Modulating Agents
@en
type
label
A Hamster Model of Diet-Induce ...... ic and Lipid Modulating Agents
@ast
A Hamster Model of Diet-Induce ...... ic and Lipid Modulating Agents
@en
prefLabel
A Hamster Model of Diet-Induce ...... ic and Lipid Modulating Agents
@ast
A Hamster Model of Diet-Induce ...... ic and Lipid Modulating Agents
@en
P2093
P2860
P1433
P1476
A Hamster Model of Diet-Induce ...... ic and Lipid Modulating Agents
@en
P2093
Gitte Hansen
Henrik B Hansen
Jacob Jelsing
Katrine Fabricius
Louise S Dalbøge
Niels Vrang
Philip J Pedersen
P2860
P304
P356
10.1371/JOURNAL.PONE.0135634
P407
P577
2015-08-12T00:00:00Z